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State-of-the-Art Papers
State-of-the-Art Paper on Cardiac Arrest
EwyandKern review the literature for the treatment of out of hospital cardiac arrestand argue that cardiocerebral resuscitation (CCR) can dramatically improve
survival, especially in patients with witnessed arrest and a shockable rhythm on arrival
of emergency medical services (EMS). CCR is composed of 3 components: 1) contin-
uous chest compressions; 2) a newEMSalgorithm; and 3) aggressive post-resuscitation
care. Continuous chest compressions improve cerebral perfusion by reducing the
interruptions to chest compressions associatedwith rescue breathing and increasing the
likelihood of layperson resuscitation. The new EMS algorithm emphasizes chest
compressions before and after defibrillation. Counties that have adopted these recom-
mendations have reported 3-fold increases in the number of patients surviving to
hospital discharge. See pages 149 and 158. See figure.
Myocardial Infarction
Pre-Hospital ECG Reduces Door-to-Balloon Time
Diercks and colleagues reviewed data from over 12,000 ST-segment elevationmyocardial infarction (STEMI) patients who were treated at a hospital partici-
pating in the NCDR-ACTION registry. Slightly more than 25% of patients trans-
ported by emergency medical service (EMS) providers had a pre-hospital electrocar-
diogram (ECG). These patients were more likely to undergo primary percutaneous
coronary intervention (PCI), and there were shorter door-to-needle times for patients
receiving fibrinolytic therapy (19 min vs. 29 min) and shorter door-to-balloon times
for patients undergoingprimaryPCI (61minvs. 75min).Therewas also a strong trend
towards lower risk-adjusted in-hospital mortality. Only 25% of confirmed STEMI
patients transported by EMS received a pre-hospital ECG, but those who did had
shorter times to reperfusion. See page 161.
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Coronary Artery Disease
Leptin Does Not Independently Increase Cardiac Risk
Obese individuals have high levels of leptin, and experimental evidence linkselevations in leptin and/or leptin resistance to atherogenesis, but the association
in humans is less well documented. Sattar and colleagues compared leptin levels in 550
men with fatal coronary heart disease (CHD) or nonfatal myocardial infarction to
1,184 control subjects. Baseline leptin correlated with several cardiac risk factors, even
after adjusting for bodymass index (BMI). Individuals in the top tertile of leptin levels
had an odds ratio for CHD of 1.25 compared with those in the lowest tertile, but this
decreased to 0.98 after adjustment for BMI. This study almost doubles the number of
incident CHD cases studied in relation to leptin levels, and suggests that the increased
risk seen with elevated leptin is primarily driven by higher BMI. See page 167.
See figure.
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Women Suspected of CAD Have Higher Medical Costs if Depressed
In almost 1,000 women referred for coronary angiography, Rutledge and colleaguesscreened for depression and then calculated the medical costs over a period of 5
years. Seventeen percent of 45% of women were depressed using the various defini-
tions. Depressed women had adjusted annual cardiovascular costs that were $1,550 to
$3,300 higher than nondepressed groups, despite having less coronary artery disease
(CAD) on the baseline angiogram. These results reinforce the importance of assessing
for depression in clinical populations and support the hypothesis that improved
management of depression can reduce medical costs. See page 176.
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Heart Failure
BBs Show Substantial Benefit in Elderly, “Real World” Patients
Beta-blockers (BBs) reduce mortality in patients with left ventricular systolicdysfunction (LVSD) enrolled in clinical trials, but these patients are not represen-
tative of the general heart failure population, particularly elderly patients. Hernandez
and colleagues combined data from the OPTIMIZE-HF registry and the Medicare
database to study the effectiveness of BBs in nonselected patients over the age of 65
years. Patients who were initiated on BBs during their initial hospitalization for
congestive heart failure and who had LVSD had an adjusted hazard ratio of 0.77 for
mortality compared with BB-eligible patients not started on a BB. Patients with
preserved systolic function had no benefit with BBs. In elderly patients hospitalized
with heart failure and LVSD, starting BBs during the initial hospitalization appears to
substantially lower the risk of death. See page 184. See figure.
Heart Failure
Prognostic Implication of BRS Testing Not Affected by BB Usage
LaRovere and colleagues assessed the impact of chronic beta-blocker (BB) use onbaroreflex sensitivity (BRS) testing, which is the change in heart rate precipitated
by a pharmacologically induced change in blood pressure. In 103 heart failure (HF)
patients treated with BBs for at least 3 months and 144 untreated patients, BRS was
significantly depressed among patients who had more severe HF and more compro-
mised left ventricular function.During follow-up, a depressedBRS (3.0ms/mmHg)
was significantly associated with poor outcomes independent of BB usage. This study
shows that BB usage does not reduce the sensitivity of BRS testing. See page 193.(continued on page A-24)
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Endothelial Dysfunction
High-Intensity Interval Exercise Ameliorates the Effects of a High-Fat Meal
Ahigh-fat meal (HFM) transiently impairs endothelial function, an effect that maybe reduced by exercise, but the mechanism responsible for this has yet to be
defined. Tyldum and colleagues performed 3 flow-mediated dilation (FMD) studies
on subjects after anHFM. For the control study, patients did not exercise for 48 h. For
the continuous moderate exercise (CME), subjects walked on a treadmill for approxi-
mately 45 min at 60% to 70% of maximal heart rate the day prior. For high-intensity
interval exercise (HIIE), subjects did four 4-min intervals of strenuous exercise. In
control and CME subjects, the brachial artery diameter was significantly decreased by
the HFM, but not in the HIIE group. FMD in the HIIE trial remained elevated
following the HFM, in contrast to the control and CME groups. Antioxidant status
was strongly correlatedwith FMD.These findings reveal a clinically relevant protective
effect of exercise that is intensity dependent and related to antioxidant capacity.
See page 200. See figure.
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Pre-Clinical Research
Sildenafil Improves Function, Prevents Dilation in
Mouse Pressure Overload Model
Recent research suggests that sildenafil (SIL) can prevent the development ofcardiac hypertrophy and dysfunction inmice subjected to pressure-overload, but
the effectiveness in models of established cardiac hypertrophy is unknown. Nagayama
and colleagues studied this inmice subjected to transverse aortic constriction (TAC) for
3 weeks to establish hypertrophy/dilation and subsequently treated with SIL (100
mg/kg/day) or placebo for 6 weeks. Mice treated with SIL had less chamber dilation,
less dysfunction, less fibrosis, and increased myocardial protein kinase G activity.
Studies from isolated myocytes suggest that SIL improved cellular calcium handling.
These results suggest that SILmaybe useful for treating hypertrophic cardiac disease by
preventing further cardiac and myocyte dysfunction and progressive remodeling.
See pages 207 and 216. See figure.
